Barr Is Barring Warfarin Competitors With Bulk Agreement; Invamed Sues
Executive Summary
Bristol-Myers Squibb's Apothecon generic business may be prevented from entering the warfarin market by an exclusive supply agreement between a crucial raw material supplier, Brantford Chemicals, and the only current generic marketer, Barr Labs.